Using 1:40 as the cutoff value for a high NPC risk, the VCA-IgA positive rate in the 30–39 and 50–59 year age groups increased from 0.3% to 0.6% in males and from 0.4% to 0.6% in females. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.